Antineutrophil cytoplasmic autoantibody-associated systemic vasculitis is associated with epstein-barr virus in the setting of HIV infection

Infectious Diseases in Clinical Practice

Volumn 21, Issue 1, 2013, Pages 50-53

  Mirsaeidi, Mehdi ^a   Syed, Fatima ^a   Jaffe, Elaine S ^b  

^a Providence Hospital Washington DC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ANCA associated vasculitis; EBV; HIV

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CYCLOPHOSPHAMIDE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANCA ASSOCIATED VASCULITIS; ARTICLE; BODY MASS; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRY THROAT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGASTRIC DISCOMFORT; EPSTEIN BARR VIRUS INFECTION; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; LYMPHADENOPATHY; MALE; PHYSICAL EXAMINATION; PLASMACYTOSIS; SYMPTOM; WESTERN BLOTTING;

EID: 84872075331     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/IPC.0b013e3182601ea1     Document Type: Article

References (12)

1. Khanna R, Burrows SR, Moss DJ. Immune regulation in Epstein-Barr virusYassociated diseases. Microbiol Rev. 1995;59:387-405.
2. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337:1512-1523.
3. Savage CO, Harper L, Adu D. Primary systemic vasculitis. Lancet. 1997;349:553-558.
4. Hoffman GS, Franck WA. Infectious mononucleosis, autoimmunity, and vasculitis. A case report. JAMA. 1979;241:2735-2736.
5. Gherardi R, Belec L, Mhiri C, et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum. 1993;36: 1164-1174.
6. Evans AS, Rothfield NF, Niederman JC. Raised antibody titres to E.B. virus in systemic lupus erythematosus. Lancet. 1971;1:167-168.
7. Gross AJ, Hochberg D, Rand WM, et al. EBV and systemic lupus erythematosus: a new perspective. J Immunol. 2005; 174:6599-6607.
8. Dutz JP, Benoit L, Wang X, et al. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood. 2001;97:95-100.
9. Dolcetti R, Gloghini A, De Vita S, et al. Characteristics of EBV-infected cells in HIV-related lymphadenopathy: implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals. Int J Cancer. 1995;63:652-659.
10. Mampaso F, Bellas C, Molina A, et al. In situ demonstration of Epstein-Barr virus in intravenous drug abusers with generalized lymphadenopathy. Postgrad Med J. 1992;68:739-741.
11. Kalungi S, Wabinga H, Bostad L. Reactive lymphadenopathy in Ugandan patients and its relationship to EBV and HIV infection. APMIS. 2009;117:302-307.
12. Hagen EC, de Keizer RJ, Andrassy K, et al. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. Clin Nephrol. 1995;43:351-359.